BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17465227)

  • 1. The prognostic significance of human epidermal growth factor receptor correlations in squamous cell cervical carcinoma.
    Fuchs I; Vorsteher N; Bühler H; Evers K; Sehouli J; Schaller G; Kümmel S
    Anticancer Res; 2007; 27(2):959-63. PubMed ID: 17465227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix.
    Lee CM; Shrieve DC; Zempolich KA; Lee RJ; Hammond E; Handrahan DL; Gaffney DK
    Gynecol Oncol; 2005 Nov; 99(2):415-21. PubMed ID: 16157365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of HER3 is associated with a decreased survival in gastric cancer.
    Hayashi M; Inokuchi M; Takagi Y; Yamada H; Kojima K; Kumagai J; Kawano T; Sugihara K
    Clin Cancer Res; 2008 Dec; 14(23):7843-9. PubMed ID: 19047113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors.
    Steffensen KD; Waldstrøm M; Andersen RF; Olsen DA; Jeppesen U; Knudsen HJ; Brandslund I; Jakobsen A
    Int J Oncol; 2008 Jul; 33(1):195-204. PubMed ID: 18575766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased survival in EGFR gene amplified vulvar carcinoma.
    Growdon WB; Boisvert SL; Akhavanfard S; Oliva E; Dias-Santagata DC; Kojiro S; Horowitz NS; Iafrate AJ; Borger DR; Rueda BR
    Gynecol Oncol; 2008 Nov; 111(2):289-97. PubMed ID: 18768215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
    Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.
    Lee CM; Lee RJ; Hammond E; Tsodikov A; Dodson M; Zempolich K; Gaffney DK
    Gynecol Oncol; 2004 Apr; 93(1):209-14. PubMed ID: 15047238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma.
    Kitagawa Y; Ueda M; Ando N; Ozawa S; Shimizu N; Kitajima M
    Clin Cancer Res; 1996 May; 2(5):909-14. PubMed ID: 9816249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor changes during breast cancer metastasis.
    Fuchs IB; Siemer I; Bühler H; Schmider A; Henrich W; Lichtenegger W; Schaller G; Kuemmel S
    Anticancer Res; 2006; 26(6B):4397-401. PubMed ID: 17201160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas.
    Shigeishi H; Higashikawa K; Hiraoka M; Fujimoto S; Mitani Y; Ohta K; Takechi M; Kamata N
    Oncol Rep; 2008 Jun; 19(6):1557-64. PubMed ID: 18497965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas.
    Baltazar F; Filho AL; Pinheiro C; Moreira MA; Queiroz GS; Oton GJ; Júnior AF; Ribeiro LF; Schmitt FC
    Int J Gynecol Pathol; 2007 Jul; 26(3):235-41. PubMed ID: 17581404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the epidermal growth factor system in endometrioid endometrial cancer.
    Ejskjaer K; Sørensen BS; Poulsen SS; Forman A; Nexø E; Mogensen O
    Gynecol Oncol; 2007 Jan; 104(1):158-67. PubMed ID: 16962163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer.
    Witton CJ; Reeves JR; Going JJ; Cooke TG; Bartlett JM
    J Pathol; 2003 Jul; 200(3):290-7. PubMed ID: 12845624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER2 and EGFR expression in cutaneous spindle squamous cell carcinoma.
    Schlauder SM; Calder KB; Moody P; Morgan MB
    Am J Dermatopathol; 2007 Dec; 29(6):559-63. PubMed ID: 18032952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gain and overexpression of the oncostatin M receptor occur frequently in cervical squamous cell carcinoma and are associated with adverse clinical outcome.
    Ng G; Winder D; Muralidhar B; Gooding E; Roberts I; Pett M; Mukherjee G; Huang J; Coleman N
    J Pathol; 2007 Jul; 212(3):325-34. PubMed ID: 17516585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
    Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
    J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix.
    Hove MG; Dinh TV; Hannigan EV; Lucci JA; Chopra V; Smith ER; To T
    J Reprod Med; 1999 Jun; 44(6):493-6. PubMed ID: 10394542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance and clinical relevance of the expression of the HER family of type I receptor tyrosine kinases in human laryngeal squamous cell carcinoma.
    Almadori G; Bussu F; Gessi M; Ferrandina G; Scambia G; Lauriola L; Paludetti G; Ranelletti FO
    Eur J Cancer; 2010 Apr; 46(6):1144-52. PubMed ID: 20149638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
    Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.